Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
AChE Inhibitor Gets Fly Boys' Attention
11 July 2002. In a small, preliminary study, researchers have found that the Alzheimer's drug donepezil (Aricept) can slightly improve the performance of older airline pilots on a flight simulator, particularly in tasks emphasizing attention. The authors hasten to caution cognitively normal people against using the drug to improve performance--the improvement is slight and there has been no research on the side-effects of the long-term use of such drugs in normal populations.

The "cholinergic hypothesis" postulates that loss of cholinergic function in the cerebral cortex underlies age-related cognitive decline. Indeed, previous experiments in older adults had suggested that boosting acetylcholine (ACh) levels (with drugs like such as donepezil that inhibit a synaptic ACh scavenging esterase) can improve performance on memory and recognition tasks.

Jerome Yesavage and colleagues at the Palo Alto (Calif.) Veterans Affairs Health Care System and several other institutions noted that pressure is beginning to mount on clinicians to prescribe AChE inhibitors to older adults (without AD or even mild cognitive impairment) for whom age-related cognitive decline can interfere with normal living. A controversial case in point is that of pilots, who are currently forced to stop flying regular passenger routes at the age of 60.

As the authors point out, the flight simulator tests required for commercial pilots are ideal for studying the effects of any number of drugs. The tests allow for the collection of reliable, highly quantifiable data, and also can be designed to focus on particular cognitive areas, such as sustained attention, working memory, or psychomotor speed.

In the double-blind, parallel study, the pilots (n = 18; avg. age 52) first practiced a series of complex piloting tasks on a simulator. Half the subjects then took donepezil 5 mg/day for thirty days, while the other half took placebos. After 30 days, the pilots who had taken donepezil showed little loss of performance on the tests learned at baseline, while the placebo group showed a significant decrement in performance. The strongest effects were on emergency tasks and approach to landing, both of which require dividing attention between a series of stimuli.

"The association of cholinergic drugs with better attention has led investigators to suggest that part of the benefit of cholinergic drugs on memory performance may be mediated through attentional components involved in working memory," write the authors, noting that their own results support this suggestion. -- Hakon Heimer

Reference:Yesavage JA, Mumenthaler MS, Taylor JL, Friedman L, O'Hara R, Sheikh J, Tinklenberg J, Whitehouse PJ. Donepezil and flight simulator performance: Effects on retention of complex skills. Neurol. Jul 2002;59:123-5. Abstract

 
Comments on News and Primary Papers
  Primary Papers: Donepezil and flight simulator performance: effects on retention of complex skills.

Permalink

This paper documents an effect that probably has been known for some time, i.e. that inhibition of acetylcholinesterase may improve memory in nondemented individuals. The effect size is, however, a major issue. This is a function not only of drug, dosage, target population, but also of the sensitivity of measurement. In this study the measurement is highly quantified and has been sensitive to a number of drug effects (alcohol, marijuana, nicotine). So one is left with the question of about how large is the effect. Our collaborator Martin Mumenthaler has been comparing effect sizes across studies and feels this effect is about the same size (though in the opposite direction) of alcohol hangover. This is not to say this should be a treatment for hangover! But, it is one attempt to get a handle on the size of a subtle drug effect. ‑ Jerome Yesavage

Food for further thought: "Although the results of this study do not suggest that current cholinergic drugs are useful for nondemented adults, it is hard to predict what drugs will be developed in the future. In their...  Read more

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad